Scott Myrand

Title: Scott Myrand: Innovator in Gene Fusion Detection

Introduction

Scott Myrand is a notable inventor based in Saline, MI (US). He has made significant contributions to the field of genetic research, particularly in the detection of gene fusions. His innovative methods have the potential to advance our understanding of genetic variations and their implications in various diseases.

Latest Patents

Scott Myrand holds a patent for "Methods for partner agnostic gene fusion detection." This method involves amplifying a nucleic acid sample using a primer pool to produce multiple amplicons. The primer pool targets various exon-exon junctions of a driver gene. The resulting amplicons are sequenced and aligned to a reference sequence. The number of reads for each amplicon is normalized to create a normalized read count. A baseline correction is then applied to these counts to form corrected read counts. A binary segmentation score is calculated for each corrected read count, allowing for the prediction of breakpoints for gene fusions without prior knowledge of specific fusion partner genes.

Career Highlights

Scott Myrand is currently employed at Life Technologies Corporation, where he continues to work on innovative solutions in genetic research. His expertise and dedication to advancing genetic detection methods have positioned him as a valuable asset in his field.

Collaborations

Throughout his career, Scott has collaborated with talented individuals such as Rajesh Gottimukkala and Amir Marcovitz. These collaborations have fostered an environment of innovation and have contributed to the success of their projects.

Conclusion

Scott Myrand's work in gene fusion detection exemplifies the impact of innovative thinking in the field of genetics. His contributions are paving the way for advancements that could significantly enhance our understanding of genetic disorders.